Patients with Schizophrenia May Have Flawed Antioxidant Defense System No comments yet
A flawed antioxidant defense system may leave schizophrenia patients' brains vulnerable to free radical attack.Medscape Medical News
Medscape Medical News
Opioid Overdose Triples in the United States, CDC Report Shows No comments yet
A new report from the Centers for Disease Control and Prevention reveals opioid-related deaths are rapidly rising.Medscape Medical News
Pump May Not Be the Culprit in “Pump Head” After CABG No comments yet
The decline in cognitive function that is often seen after CABG may not be related to the use of cardiopulmonary bypass or to embolic debris in the bloodstream from the bypass pump, Chinese researchers say.Heartwire
No Link Between Strep Infections and OCD or Tourette Syndrome No comments yet
A new study suggests there is no basis for a link between streptococcal infections and the subsequent onset of neuropsychiatric disorders including OCD and Tourette syndrome.Medscape Medical News
Another Study Links Pesticides to Parkinson’s Disease No comments yet
A new case-control study finds that occupational pesticide use was associated with a significantly increased risk for parkinsonism and implicates particular pesticides as culprits.Medscape Medical News
Only 1 in 8 Strokes Heralded by TIA No comments yet
A new study finds only about 1 in 8 strokes are preceded by transient ischemic attack. The results underline the need for a broader approach to primary prevention, researchers say.Medscape Medical News
APA Endorses New Health Reform Bill, Public Insurance Option No comments yet
The APA is optimistic its endorsement of the new health reform bill and a voluntary public insurance option will help level the playing field for the mentally ill.Medscape Medical News
Diabetes: An Independent Risk Factor for AF No comments yet
Atrial fibrillation was more likely to develop in diabetics than in nondiabetics in a new observational study, and the link was particularly strong in women.Heartwire
Monoclonal Antibodies in Multiple Sclerosis Treatment: Current and Future Steps No comments yet
Experience with monoclonal antibodies has shown that early, effective treatment of MS has the potential to prevent or delay disability.Therapeutic Advances in Neurological Disorders
Is Xenon a Future Neuroprotectant? No comments yet
This review describes the NMDA receptor-related mechanisms of ischemic brain injury and focuses on the research progress into xenon’s neuroprotective effects and paradigms.Future Neurology